TRIMEDX, an industry-leading provider of clinical engineering, medical device cybersecurity and clinical asset management solutions to healthcare providers, announced the acquisition of Centurion Service Group, a full-service surplus medical equipment management company, to expand its Clinical Asset Management offering. The added capabilities of Centurion will allow TRIMEDX clients to gain maximum value from their excess medical …
Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December 31, 2020. He will be replaced as President and Chief Executive Officer by Thomas Burnell, PhD., effective December 1, 2020. Mr. Stover, who will step down from the Interpace Board of Directors once Dr. Burnell joins …
Colorescience® announces the published results of their latest study “Iron oxides in novel skin care formulations attenuate blue light for enhanced protection against skin damage” authored by Eric F. Bernstein MD, MSE, Harry W. Sarkas PhD, and Patricia Boland BA in The Journal of Cosmetic Dermatology. The study assessed the efficacy of iron oxides in blocking HEV (Blue Light) when included in specific …
Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products that enhance clinical outcomes, announced today that it has entered into an exclusive supply and distribution agreement with Gunze Limited for TheraGenesis® Bilayer Wound Matrix. TheraGenesis is a proprietary, FDA cleared, porcine tendon derived collagen wound matrix with a …
Aktana, the pioneer in intelligent engagement for the life sciences industry, introduces its next-generation Contextual Intelligence Engine to optimize interactions with healthcare professionals (HCPs). Aktana’s Contextual Intelligence Engine combines advanced artificial intelligence technologies and human intelligence to align life sciences commercial teams’ engagement with HCPs across channels.
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, today announced it has delivered more than 500,000 TMS treatments since the Company was founded in 2011.
ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis (NASH), diabetes, obesity, and related metabolic diseases, announced today the closing of a growth financing from 1315 Capital, a healthcare investment firm that provides expansion and growth capital to commercial-stage healthcare services, medical technology and specialty therapeutics companies. SVB Leerink served as …
Innovative Health, Inc. today announced it has received FDA clearance for reprocessing the St. Jude Medical BRK Transseptal Needle and the Baylis Medical NRG Transseptal Needle. Innovative Health’s clearance to reprocess these market-leading transseptal needles is a milestone in single-use device reprocessing, as no other company is able to offer reprocessed transseptal needles and unlock additional …
Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company, is pleased to announce the launch of a new brush-on powder sunscreen as part of their award-winning Total Protection™ portfolio. Well-regarded as the leader in innovative mineral sunscreen, Colorescience has applied their proprietary EnviroScreen™ Technology to formulate their market-leading sunscreen brush specifically for those with oily, …
Nutrition21, LLC (“Nutrition21“) has announced the conclusion of a dispute with MythLabs following MythLabs’ agreement to cease any further intellectual property (IP) infringement of Nutrition21’s ingredient Nitrosigine®. Nutrition21 discovered a product being sold in the marketplace, MythLabs Pump, that claimed to include the powerful NO booster Nitrosigine without a purchase and trademark license agreement. Upon …
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) is pleased to announce the closing of its previously announced public offering (the “Offering”) of common shares of the Company (the “Offered Shares”). The Offering was made pursuant to an agency agreement (the “Agency Agreement”) entered into among Bloom Burton Securities Inc. and Clarus Securities Inc., …
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) announced today that it has priced its previously announced overnight marketed offering (the “Offering”) of common shares of the Company (the “Offered Shares”). The Company intends to issue a minimum of 8,484,849 Offered Shares and a maximum of 10,909,091 Offered Shares at a price of C$1.65 …